Men, on average, live about five years less than women worldwide—a persistent gap observed across diverse populations and historical periods. Even as lifestyle factors such as risk-taking behaviors, occupational hazards and delayed healthcare seeking have often been cited as explanations, recent scientific research points to a more fundamental biological mechanism: a specific genetic advantage present in females that may confer greater longevity. This emerging understanding shifts the focus from behavioral differences alone to intrinsic cellular processes influenced by sex chromosomes.
The disparity in life expectancy between men and women is one of the most consistent patterns in demography. According to data from the World Health Organization, global life expectancy at birth in 2021 was 73.8 years for women and 68.4 years for men—a difference of 5.4 years. This gap has remained relatively stable over decades, even as overall life expectancy has increased due to advances in medicine, sanitation, and public health infrastructure. In high-income countries, the difference tends to be slightly larger, while in some low-income settings, it narrows but rarely disappears entirely.
For years, scientists attributed this gap largely to men’s higher exposure to preventable risks: smoking, alcohol consumption, dangerous occupations, and lower rates of preventive medical care. Men are also more likely to die from heart disease, accidents, and violence—conditions often linked to behavioral and social factors. Although, these explanations do not fully account for the persistence of the gap even in populations with similar lifestyles or in controlled environments where external risks are minimized.
Recent research has turned attention to biological differences, particularly the role of the X chromosome and a phenomenon known as X-chromosome inactivation. Females possess two X chromosomes, while males have one X and one Y. To prevent an overdose of X-linked gene products, one of the two X chromosomes in female cells is randomly inactivated early in development—a process called lyonization. However, not all genes on the inactivated X are silenced; some escape this inactivation and remain active, potentially providing a genetic buffer.
One such gene that has drawn scientific interest is KDM6A, located on the X chromosome. This gene encodes a histone demethylase enzyme involved in regulating chromatin structure and gene expression. Because it often escapes inactivation, females may benefit from higher or more stable expression of KDM6A compared to males, who have only one copy. Studies in model organisms and human cell lines suggest that KDM6A plays a role in cellular senescence, stress resistance, and DNA repair—processes directly tied to aging and age-related diseases.
A 2020 study published in Nature Communications analyzed data from human twins and found that female twins had higher expression levels of KDM6A in blood cells than male twins, even after adjusting for age and cell composition. The researchers noted that this difference was more pronounced in older individuals, suggesting a potential protective effect that becomes increasingly relevant with age. While the study did not establish causation, it highlighted KDM6A as a candidate gene contributing to sex differences in aging trajectories.
Further support comes from research on Klinefelter syndrome (XXY), a condition in which males are born with an extra X chromosome. Men with this condition tend to have longer lifespans than typical XY males, approaching those of XX females. Conversely, Turner syndrome (X0), where females lack a second X chromosome, is associated with increased risks of certain autoimmune and cardiovascular conditions, though lifespan data are more complex due to comorbidities. These genetic conditions underscore the potential influence of X-chromosome dosage on longevity.
no single “sleep gene” or master regulator of aging has been identified, despite sensational claims in some media reports. The term “沉睡基因” (sleeping gene) used in the original source appears to be a metaphorical or colloquial expression not recognized in scientific literature. Aging is a multifactorial process influenced by hundreds of genes, epigenetic modifications, mitochondrial function, telomere dynamics, and environmental interactions. Attributing the male-female lifespan gap to one gene oversimplifies a highly complex biological system.
Nonetheless, the growing evidence for X-chromosome-related mechanisms offers a compelling complement to behavioral and social explanations. Scientists now emphasize an integrated model in which biological vulnerabilities interact with lifestyle choices and healthcare access. For example, men may be biologically more susceptible to oxidative stress or inflammation, and these tendencies could be exacerbated by higher rates of smoking or delayed diagnosis of hypertension or diabetes.
Understanding these mechanisms has practical implications for preventive medicine and therapeutic development. If certain protective pathways linked to the X chromosome can be identified and modulated, it may open avenues for interventions that benefit both sexes—such as senolytics, which target senescent cells, or NAD+ boosters that support mitochondrial function. Clinical trials exploring such approaches are already underway for age-related conditions like frailty, Alzheimer’s disease, and cardiovascular decline.
Public health strategies should continue to address modifiable risk factors disproportionately affecting men, including encouraging earlier engagement with healthcare systems, reducing stigma around mental health support, and promoting workplace safety. At the same time, ongoing research into sex differences in aging must be supported through inclusive study designs that analyze data by sex and gender, ensuring that findings are applicable across populations.
As of now, no major clinical guidelines recommend sex-specific longevity interventions based solely on genetic makeup. However, organizations such as the National Institute on Aging (NIA) and the European Union’s Joint Programme on Neurodegenerative Disease Research (JPND) actively fund studies investigating the biological basis of sex differences in aging. Researchers involved in these efforts stress the importance of avoiding deterministic narratives while recognizing that biological sex influences health trajectories in measurable ways.
The next step in this field involves larger, longitudinal studies that integrate multi-omics data—genomics, transcriptomics, proteomics—with detailed phenotyping and lifestyle tracking. Initiatives like the UK Biobank and the All of Us Research Program in the United States are beginning to provide the scale and depth needed to uncover how genetic, hormonal, and environmental factors interact over time to shape health outcomes.
While the idea of a single “sleep gene” explaining why women live longer remains unverified and likely inaccurate, the science clearly shows that biological sex plays a meaningful role in aging through mechanisms involving chromosomal dosage, gene expression regulation, and cellular resilience. Recognizing these factors does not diminish the importance of behavior or social context but rather enriches our understanding of how to promote longer, healthier lives for everyone.
For readers interested in staying informed about developments in aging research and public health, trusted sources include the World Health Organization’s ageing and health portal, the National Institutes of Health’s National Institute on Aging website, and peer-reviewed journals such as Nature Aging and Journals of Gerontology. These platforms regularly publish updates on ongoing studies, clinical trials, and evidence-based recommendations for healthy aging.
What are your thoughts on the interplay between biology and behavior in shaping lifespan differences? Share your perspective in the comments below, and consider sharing this article with others who may find it useful in understanding one of the most enduring patterns in human health.